Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Acta Biomater. 2010 Aug 20;7(1):225–233. doi: 10.1016/j.actbio.2010.08.013

Figure 1.

Figure 1

ePCL nanofibers are coated with NO releasing PAs to help them tackle the issues faced by current cardiovascular implants. The PAs possess cell adhesive ligands and NO donor residues, and are self-assembled onto the surface of ePCL nanofibers by solvent evaporation technique. Presence of YIGSR ligands and release of NO promote the adhesion and proliferation of endothelial cells, while simultaneously limiting the adhesion and proliferation of smooth muscle cells, and the adhesion and activation of platelets.